IVF Side Effects: Myths vs Facts
If you are considering in-vitro fertilisation (IVF), chances are you have already encountered a bewildering mix of reassurance and alarm about its side effects. Online forums warn of permanent weight gain, cancer risk, and depleted egg reserves. Medical professionals say the procedure is safe. Who should you believe?
The answer, as with most things in medicine, lies in the evidence. IVF is one of the most extensively studied fertility treatments in the world – with over 9 million babies born globally through assisted reproductive technology (ART). It does produce side effects, most of which are mild, predictable, and temporary. The challenge is that misinformation has amplified rare complications into common expectations, creating unnecessary fear that delays treatment and increases emotional distress.
This page provides a comprehensive, medically reviewed breakdown of IVF side effects – separating what the evidence supports from what the internet exaggerates. At FertilTree, based at Jaslok Hospital, Mumbai, our approach is rooted in transparency – we believe informed patients make better decisions and experience less anxiety.
ⓘ Who is this page for?
Women preparing for their first IVF cycle who want to know what side effects to expect.
Couples who have read conflicting information online and want evidence-based clarity.
Patients who have experienced side effects in a previous cycle and want to understand whether they were normal.
Anyone whose fear of IVF side effects is delaying or preventing them from starting treatment.
Clinically Documented IVF Side Effects: What the Evidence Says
The IVF process involves several distinct phases – ovarian stimulation, egg retrieval, fertilisation, and embryo transfer – each of which can produce specific, well-characterised side effects. Understanding which phase causes which symptoms helps patients distinguish normal responses from warning signs. For a detailed walkthrough, see our step-by-step IVF procedure guide.
During Ovarian Stimulation (Days 1–14)
Ovarian stimulation uses injectable gonadotrophins (FSH, LH, or combinations) to recruit multiple follicles in a single cycle. As the ovaries enlarge and oestrogen levels rise, the following side effects are commonly reported:
- Abdominal bloating and pelvic heaviness: Caused by enlarged ovaries and fluid retention. This is the most frequently reported symptom and resolves after retrieval.
- Breast tenderness: A direct effect of elevated oestradiol. Similar to premenstrual breast soreness, but often more pronounced.
- Mood fluctuations: Hormonal shifts during stimulation can cause irritability, tearfulness, or anxiety. These are transient and not indicative of a lasting psychological effect.
- Injection site reactions: Minor bruising, redness, or itching at subcutaneous injection sites. Rotating injection locations and using ice packs before injection minimises discomfort.
- Headaches and fatigue: Reported in approximately 10–15% of patients during the stimulation phase. Typically mild and manageable with rest and hydration.
For more on what the injections involve, read: How Many Injections Are Needed for IVF Treatment?
After Egg Retrieval
Egg retrieval (oocyte pick-up) is a minor surgical procedure performed under mild anaesthesia using transvaginal ultrasound guidance. Post-procedural side effects include:
- Mild to moderate pelvic cramping: Similar to menstrual cramps. Usually resolves within 24–48 hours with rest and over-the-counter analgesics.
- Light vaginal spotting: A small amount of bleeding from the needle puncture sites is normal and typically stops within a day.
- Nausea: Related to anaesthesia rather than the procedure itself. Usually short-lived.
- Pelvic infection (rare): Occurs in fewer than 0.5% of cases. Prophylactic antibiotics are administered at FertilTree to minimise this risk.
After Embryo Transfer and During the Two-Week Wait
Embryo transfer itself is a painless, catheter-based procedure that does not require anaesthesia. However, the progesterone supplementation prescribed to support implantation can produce symptoms including constipation, breast soreness, mild bloating, and fatigue. These are medication effects, not complications. For more on what to look for post-transfer, see: Early Signs of a Successful Embryo Transfer.
IVF Side Effect Myths: What the Research Actually Shows
The following beliefs are among the most commonly encountered IVF myths. Each is addressed below with reference to the best available clinical evidence.
Myth 1: “IVF Causes Permanent Weight Gain”
The evidence: Weight fluctuations during IVF are primarily caused by fluid retention due to elevated oestrogen during ovarian stimulation. This is temporary. A prospective cohort study published in Fertility and Sterility found that body weight returned to pre-treatment baseline within one menstrual cycle after the end of stimulation in the vast majority of participants. Long-term weight gain attributable to IVF itself is not supported by published data.
Myth 2: “Fertility Drugs Increase Cancer Risk”
The evidence: This is perhaps the most anxiety-inducing myth, and one that has been rigorously investigated. A landmark cohort study by van Leeuwen et al. (2011), published in Human Reproduction, followed over 25,000 women for a median of 15 years and found no significant increase in overall cancer risk among women who underwent ovarian stimulation compared with the general population. A 2019 systematic review in the BMJ corroborated these findings for breast, ovarian, and endometrial cancers. While individual risk factors should always be discussed with your specialist, IVF medications as a class do not carry an elevated cancer risk.
Myth 3: “IVF Always Leads to Severe OHSS”
The evidence: Ovarian Hyperstimulation Syndrome (OHSS) is a real, recognised complication – but the word “always” is the myth. Mild OHSS (bloating, mild nausea) occurs in approximately 20–33% of stimulated cycles. Moderate-to-severe OHSS, involving significant fluid shifts, ascites, or hospitalisation, affects fewer than 1–5% of patients with modern protocols (Humaidan et al., Human Reproduction Update, 2011). Key prevention strategies now used at FertilTree include the GnRH antagonist protocol, agonist trigger (instead of hCG) for final oocyte maturation, freeze-all strategy when hyperstimulation risk is high, individualised gonadotrophin dosing based on AMH and antral follicle count, and coasting when oestradiol rises excessively. Women with PCOS or high AMH levels are at higher risk and receive intensified monitoring.
⚠️ Clinical note
Using a GnRH agonist as the ovulation trigger in an antagonist protocol virtually eliminates the risk of severe OHSS. However, in such cases fresh embryo transfer is not recommended, and a freeze-all approach is adopted. This does not reduce overall success rates – in fact, frozen embryo transfer (FET) has been shown to produce comparable or superior outcomes in many patient groups.
Myth 4: “IVF Uses Up All Your Eggs and Causes Early Menopause”
The evidence: In every natural menstrual cycle, the ovaries recruit a cohort of approximately 10–20 antral follicles. Under normal conditions, only one follicle reaches dominance and ovulates – the rest undergo atresia (programmed cell death) and are reabsorbed. IVF medications rescue follicles that were already destined to be lost, allowing multiple eggs to mature in a single cycle. The treatment does not access the dormant primordial follicle pool that determines when menopause occurs. Multiple longitudinal studies have confirmed that women who undergo IVF do not experience earlier menopause than women who do not (Practice Committee, ASRM, 2016).
Myth 5: “IVF Pregnancies Are Always High-Risk”
The evidence: Once an IVF pregnancy is established and confirmed by rising hCG levels and ultrasound, it is physiologically indistinguishable from a naturally conceived pregnancy. The historical association between IVF and high-risk pregnancy was driven primarily by multiple embryo transfers (leading to twin and higher-order pregnancies) and the underlying medical conditions that necessitated IVF in the first place (advanced maternal age, endometriosis, PCOS). With the now-standard practice of single embryo transfer (SET), multiple pregnancy rates have declined dramatically, and singleton IVF pregnancies carry outcomes comparable to spontaneous conceptions (Pinborg et al., Human Reproduction, 2013).
Related reading: IVF Success Rates by Age – What Impacts Your Chances?
How to Minimise and Manage IVF Side Effects
The severity of IVF side effects is not purely a matter of chance – it is significantly influenced by the quality of your clinical team, the protocol used, and your own preparation. The following strategies are grounded in clinical practice and patient experience at FertilTree:
- Individualised stimulation protocol: Your fertility specialist should tailor the type and dose of gonadotrophins to your age, body weight, AMH, antral follicle count, and response history. Over-stimulation is the primary driver of OHSS and discomfort.
- Regular monitoring: Frequent transvaginal ultrasound and oestradiol blood tests allow real-time dose adjustments. At FertilTree, follicular growth is tracked every 2–3 days during stimulation.
- Hydration and nutrition: A protein-rich diet and adequate fluid intake (2–3 litres daily) help manage bloating and support recovery post-retrieval. Electrolyte-rich fluids are recommended if mild OHSS symptoms develop.
- Emotional and psychological support: IVF is emotionally demanding. FertilTree provides access to a dedicated fertility counsellor, because managing the psychological dimension of treatment is as important as managing the physical one.
- Know when to call: Severe abdominal pain, rapid weight gain (>1 kg/day), difficulty breathing, persistent vomiting, or heavy vaginal bleeding require immediate medical evaluation.
Why Choose FertilTree for Your IVF Treatment?
Not every fertility clinic approaches side effect management with the same rigour. Here is what distinguishes FertilTree as a trusted IVF centre in Mumbai:
Over 35 Years of Clinical Excellence
FertilTree IVF Centre, based at Jaslok Hospital, is led by Dr. Firuza Parikh, one of India’s most recognised fertility specialists. Dr. Parikh holds the Padma Shri (India’s fourth-highest civilian honour), the FRCOG from the Royal College of Obstetricians and Gynaecologists, London, and has published extensively in peer-reviewed journals. The clinic has been ranked as the top IVF centre in Mumbai and nationally by the Times of India Health survey.
Personalised, Low-Risk Protocols
Every stimulation protocol at FertilTree is tailored to the individual patient. Dosing is guided by AMH, antral follicle count, age, body weight, and prior cycle response. The team routinely employs antagonist protocols, agonist triggers, and freeze-all strategies to minimise OHSS risk without compromising success rates.
Integrated Emotional Support
IVF is not just a physical process. FertilTree’s dedicated fertility counsellor supports patients through every stage – from pre-treatment anxiety to the emotional intensity of the two-week wait – because managing the mind is as important as managing the body.
Transparent Communication
Patients receive detailed, written treatment plans before every cycle. Expected side effects, risk mitigation strategies, and clear instructions on when to contact the clinic are discussed upfront. FertilTree shares individualised success rate estimates during consultation based on clinical data.
Frequently Asked Questions
Are IVF side effects the same for everyone?
No. Side effects vary significantly depending on the individual’s age, ovarian reserve (AMH and antral follicle count), body weight, the stimulation protocol used, and overall health. Women with PCOS, for example, are more susceptible to bloating and OHSS, while women with low ovarian reserve may experience fewer stimulation-related symptoms but may need higher medication doses.
Can IVF side effects affect the success of the cycle?
Mild side effects do not negatively impact cycle outcomes. In fact, some degree of bloating and breast tenderness indicates that the ovaries are responding to stimulation as intended. However, severe OHSS may necessitate cancelling fresh embryo transfer and adopting a freeze-all approach – which does not reduce cumulative pregnancy rates. Read more: IVF vs IUI: The Complete Guide.
Will I experience side effects in every IVF cycle?
Not necessarily. Each cycle can produce different responses depending on the protocol, medication dosages, and your body’s hormonal state at the time. Your fertility specialist adjusts the approach based on previous cycle outcomes, which often results in fewer or milder side effects in subsequent attempts.
How long do IVF side effects last?
Most stimulation-related side effects (bloating, breast tenderness, mood changes) resolve within 7–10 days after egg retrieval. Mild OHSS symptoms typically subside within 10–12 days. Progesterone supplementation effects persist until the medication is discontinued (usually at 10–12 weeks of pregnancy if the cycle is successful, or when a period occurs if not).
Is emotional distress during IVF a “side effect”?
It is increasingly recognised as one. A review published in Human Reproduction Update (2007) found that psychological distress – including anxiety and depressive symptoms – is common during IVF treatment and is influenced by both hormonal changes and the emotional weight of the fertility journey. This is precisely why FertilTree integrates counselling support into every treatment pathway.
What is the difference between IVF side effects and IVF risks?
Side effects are expected, usually mild, and self-limiting responses to treatment (e.g., bloating, breast tenderness). Risks are uncommon, potentially serious complications that require medical intervention (e.g., severe OHSS, pelvic infection, ectopic pregnancy). The distinction matters because it allows patients to prepare for what is normal while remaining vigilant for what requires immediate attention. See: Symptoms of Failed Implantation.
